S. Scott Graham is an Assistant Professor of Rhetorical Theory and History at the University of British Columbia. There he studies rhetorics of technoscience and medicine. Scott has particular interests in agency theory, theories of socio-political change, actor-network theory, and new media studies. His current research explores communicative conflicts and argumentative practices in the intersections among scientific research and regulatory policy. Currently, he is exploring these issues through inquiry into two different cases: 1) the FDA-pain science interface and 2) the community government-agronomy interface.
Scott’s current book manuscript, tentatively entitled A Nonmodern Pain Science: Agency and ontology in the medical-industrial complex chronicles three years of ethnographic research into an interdisciplinary activist pain management organization. Scott explores the rhetoric of this organization as its members attempt to forge cross-disciplinary alliances in the face of profound incommensurability and endeavor to change the theoretical foundation of Western biomedicine and the regulatory policies of the FDA.
About
S. Scott Graham is an Assistant Professor of Rhetorical Theory and History at the University of British Columbia. There he studies rhetorics of technoscience and medicine. Scott has particular interests in agency theory, theories of socio-political change, actor-network theory, and new media studies. His current research explores communicative conflicts and argumentative practices in the intersections among scientific research and regulatory policy. Currently, he is exploring these issues through inquiry into two different cases: 1) the FDA-pain science interface and 2) the community government-agronomy interface.
Scott’s current book manuscript, tentatively entitled A Nonmodern Pain Science: Agency and ontology in the medical-industrial complex chronicles three years of ethnographic research into an interdisciplinary activist pain management organization. Scott explores the rhetoric of this organization as its members attempt to forge cross-disciplinary alliances in the face of profound incommensurability and endeavor to change the theoretical foundation of Western biomedicine and the regulatory policies of the FDA.